Colon-Otero, G <br/><br/>
A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial.  [electronic resource] 

 -  American journal of clinical oncology  Dec 2001 
 - 551-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0277-3732 
<br/><br/><label>Standard No.: </label>10.1097/00000421-200112000-00004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Aminopterin--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cisplatin--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Filgrastim<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Recombinant Proteins<br/>Remission Induction<br/>Sickness Impact Profile<br/>Survival Analysis<br/>Vinblastine--administration & dosage